Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Visseaux

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|October 26, 2012
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNABenoit Visseaux, Charlotte Charpentier, Audrey Taieb, et al.
AIDS (London, England)|September 30, 2014
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patientsBenoit Visseaux, Charlotte Charpentier, Caroline Rouard, et al.
Journal of Virology|January 10, 2020
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional ActivityQuentin Le Hingrat, Benoit Visseaux, Mélanie Bertine, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patientsMarine Perrier, Mélanie Bertine, Quentin Le Hingrat, et al.
Virus Evolution|August 23, 2021
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolutionBenoit Visseaux, Mélanie Bertine, Quentin Le Hingrat, et al.
Retrovirology|December 23, 2018
Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassificationNathalie Désiré, Lorenzo Cerutti, Quentin Le Hingrat, et al.
The Journal of Infectious Diseases|December 6, 2011
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic toolBenoit Visseaux, Margarita Hurtado-Nedelec, Charlotte Charpentier, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitorsBenoit Visseaux, Charlotte Charpentier, Margarita Hurtado-Nedelec, et al.
The Journal of Infection|March 12, 2022
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assaysValentine Marie Ferré, Samuel Lebourgeois, Houssem Redha Chenane, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2015
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional studyPaul Loubet, Charlotte Charpentier, Benoit Visseaux, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|October 26, 2012
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNABenoit Visseaux, Charlotte Charpentier, Audrey Taieb, et al.
AIDS (London, England)|September 30, 2014
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patientsBenoit Visseaux, Charlotte Charpentier, Caroline Rouard, et al.
Journal of Virology|January 10, 2020
Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional ActivityQuentin Le Hingrat, Benoit Visseaux, Mélanie Bertine, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patientsMarine Perrier, Mélanie Bertine, Quentin Le Hingrat, et al.
Virus Evolution|August 23, 2021
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolutionBenoit Visseaux, Mélanie Bertine, Quentin Le Hingrat, et al.
Retrovirology|December 23, 2018
Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassificationNathalie Désiré, Lorenzo Cerutti, Quentin Le Hingrat, et al.
The Journal of Infectious Diseases|December 6, 2011
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic toolBenoit Visseaux, Margarita Hurtado-Nedelec, Charlotte Charpentier, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitorsBenoit Visseaux, Charlotte Charpentier, Margarita Hurtado-Nedelec, et al.
The Journal of Infection|March 12, 2022
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assaysValentine Marie Ferré, Samuel Lebourgeois, Houssem Redha Chenane, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2015
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional studyPaul Loubet, Charlotte Charpentier, Benoit Visseaux, et al.
Pageof 14